WestEnd Advisors’s Moderna MRNA Stock Holding History

WestEnd Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.37K	Hold	27	–	–	﹤0.01%	193
2025 Q4	$796	Buy	27 +15	+125%	+$408	﹤0.01%	266
2025 Q3	$310	Sell	12 -2	-14%	-$56	﹤0.01%	354
2025 Q2	$386	Buy	14 +1	+8%	+$26	﹤0.01%	303
2025 Q1	$369	Buy	13 +9	+225%	+$319	﹤0.01%	297
2024 Q4	$166	Hold	4	–	–	﹤0.01%	279
2024 Q3	$267	Hold	4	–	–	﹤0.01%	258
2024 Q2	$475	Sell	4 -1	-20%	-$127	﹤0.01%	165
2024 Q1	$533	Hold	5	–	–	﹤0.01%	149
2023 Q4	$497	Hold	5	–	–	﹤0.01%	160
2023 Q3	$516	Buy	+5	New	+$558	﹤0.01%	150
2023 Q2	–	Hold	0	–	-$614	–	213
2023 Q1	–	Sell	-4	Closed	-$660	–	138
2022 Q4	$718	Hold	4	–	–	﹤0.01%	122
2022 Q3	$0	Hold	4	–	–	﹤0.01%	268
2022 Q2	$571	Buy	+4	New	+$572	﹤0.01%	131
2022 Q1	–	Sell	-3	Closed	-$505	–	148
2021 Q4	$761	Buy	+3	New	+$877	﹤0.01%	123
2021 Q3	–	Hold	0	–	–	–	93

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return